OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse
Xiaoyan Lin, Zhili Xu, Lawrence M. Carey, et al.
Pain (2021) Vol. 163, Iss. 5, pp. 834-851
Open Access | Times Cited: 25

Showing 25 citing articles:

Interactions between skin-resident dendritic and Langerhans cells and pain-sensing neurons
Natalie C Wilcox, Golnar Taheri, Katherine Halievski, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 11-19
Open Access | Times Cited: 5

A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
Ming Jiang, Mirjam Huizenga, Jonah L. Wirt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15

Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment
Marina Mattar, Florence Umutoni, Ahmed S. Hassan, et al.
Life (2024) Vol. 14, Iss. 8, pp. 991-991
Open Access | Times Cited: 4

Update on the controversial identity of cells expressing cnr2 gene in the nervous system
Wanda Grabon, Jacques Bodennec, Sylvain Rheims, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 3, pp. 760-770
Open Access | Times Cited: 11

Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic
Nicola Gambacorta, Valeria Gasperi, Tatiana Guzzo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115647-115647
Closed Access | Times Cited: 10

Targeting sensory neuron GPCRs for peripheral neuropathic pain
Ankit Uniyal, Vinod Tiwari, Takashi Tsukamoto, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 1009-1027
Open Access | Times Cited: 10

The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy
Iddrisu Ibrahim, Joseph Ayariga, Junhuan Xu, et al.
(2024)
Open Access | Times Cited: 3

Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids
Nima Zafari, Mahla Velayati, Mina Maftooh, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 16, pp. 1245-1265
Closed Access | Times Cited: 8

Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain
Kelsey G. Guenther, Zhili Xu, Julián Romero, et al.
Neuropharmacology (2023) Vol. 237, pp. 109601-109601
Closed Access | Times Cited: 7

Centralizing the Knowledge and Interpretation of Pain in Chemotherapy-Induced Peripheral Neuropathy: A Paradigm Shift towards Brain-Centric Approaches
Mário Cunha, Isaura Tavares, José Tiago Costa‐Pereira
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 659-659
Open Access | Times Cited: 1

Lack of Cannabinoid Type 2 Promoter Activity in Normal or Injured Kidneys Using a Cnr2-GFP Reporter Mouse
Avery G. Boals, Daniel M. Collier, Julián Romero, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access | Times Cited: 1

The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats
Kelsey G. Guenther, Jonah L. Wirt, Idaira Oliva, et al.
Neuropharmacology (2024) Vol. 265, pp. 110257-110257
Closed Access | Times Cited: 1

Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits
Anthony S. Ferranti, Daniel J. Foster
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6

Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS
Armin Kouchaeknejad, Gunter van der Walt, Maria Helena de Donato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15829-15829
Open Access | Times Cited: 3

Preclinical research in paclitaxel-induced neuropathic pain: a systematic review
Carolina Bacalhau, José Tiago Costa‐Pereira, Isaura Tavares
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 3

The role of cannabinoid CB1 receptors in the antinociceptive and reparative actions of mesenchymal stem cells in rats with peripheral neuropathic pain
A.-M. V. Yerofeyeva, Sergey V. Pinchuk, Svetlana Rjabceva, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 245-257
Open Access | Times Cited: 2

ART26.12, a novel fatty acid‐binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models
W. G. Warren, Mary Osborn, Ana David-Pereira, et al.
European Journal of Pain (2024) Vol. 29, Iss. 2
Open Access

Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of neuropathic pain
Lawrence M. Carey, Zhili Xu, Gabriela Rajic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 1

Cannabinoids to Fight Chemotherapy-Induced Adverse Effects
Ana Bagüés, David Benítez, Raquel Abalo
Springer eBooks (2023), pp. 1-28
Closed Access

Cannabinoids to Fight Chemotherapy-Induced Adverse Effects
Ana Bagüés, David Benítez, Raquel Abalo
Springer eBooks (2023), pp. 1-29
Closed Access

Unlocking the Healing Potential
Hania Shahzad, Maximillian Lee, Vikas Munjal, et al.
JBJS Reviews (2023) Vol. 11, Iss. 11
Closed Access

Page 1

Scroll to top